The city of Lubbock, Texas, currently has 1 active clinical trials seeking participants for Crohn's Disease research studies.
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Recruiting
The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/16/2024
Locations: West Texas Digestive Disease, Lubbock, Texas
Conditions: Crohn's Disease